Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy

Bibliography

• Sheridan C. Gene therapy finds its niche. Nat Biotechnol 2011;29(2):121-8
   PubMed Web of Science ®Google Scholar
• Das SK, Menezes ME, Bhatia S, et al. Gene therapies for cancer: strategies, challenges and successes. J Cell Physiol 2015;230:259-71
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Kormann M, Rosenecker J, Rudolph C. Current prospects for mRNA gene delivery. Eur J Pharm Biopharm 2009;71(3):484-9
   PubMed Web of Science ®Google Scholar
• Phua KK, Leong KW, Nair SK. Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format. J Control Release 2013;166(3):227-33
   PubMed Web of Science ®Google Scholar
• Malone RW, Felgner PL, Verma IM. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 1989;86(16):6077-81
   PubMed Web of Science ®Google Scholar
• Van Tendeloo VF, Ponsaerts P, Lardon F, et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 2001;98(1):49-56
   PubMed Web of Science ®Google Scholar
• Stepinski J, Waddell C, Stolarski R, et al. Synthesis and properties of mRNAs containing the novel “anti-reverse” cap analogs 7-methyl(3’-O-methyl)GpppG and 7-methyl (3’-deoxy)GpppG. RNA 2001;7(10):1486-95
   PubMed Web of Science ®Google Scholar
• Strenkowska M, Kowalska J, Lukaszewicz M, et al. Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications. New J Chem 2010;34(5):993-1007
   PubMed Web of Science ®Google Scholar
• Zohra FT, Chowdhury EH, Tada S, et al. Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection. Biochem Biophysic Res Comm 2007;358(1):373-8
   PubMed Web of Science ®Google Scholar
• Eberhardt W, Doller A, Akool E-S, Pfeilschifter J. Modulation of mRNA stability as a novel therapeutic approach. Pharmacol Ther 2007;114(1):56-73
   PubMed Web of Science ®Google Scholar
• Banerjee AK. 5’-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev 1980;44(2):175-205
   PubMedGoogle Scholar
• Izaurralde E, Lewis J, McGuigan C, et al. A nuclear cap binding protein complex involved in pre-mRNA splicing. Cell 1994;78(4):657-68
   PubMed Web of Science ®Google Scholar
• Coutts M, Krowczynska A, Brawerman G. Protection of mRNA against nucleases in cytoplasmic extracts of mouse sarcoma ascites cells. Biochim Biophys Acta 1993;1173(1):49-56
   PubMed Web of Science ®Google Scholar
• Izaurralde E, Stepinski J, Darzynkiewicz E, Mattaj IW. A cap binding protein that may mediate nuclear export of RNA polymerase II-transcribed RNAs. J Cell Biol 1992;118(6):1287-95
   PubMed Web of Science ®Google Scholar
• Gallie DR. The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev 1991;5(11):2108-16
   PubMed Web of Science ®Google Scholar
• Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Ann Rev Biochem 1999;68:913-63
   PubMed Web of Science ®Google Scholar
• Mathonnet G, Fabian MR, Svitkin YV, et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 2007;317(5845):1764-7
   PubMed Web of Science ®Google Scholar
• Zdanowicz A, Thermann R, Kowalska J, et al. Drosophila miR2 primarily targets the m7GpppN cap structure for translational repression. Mol Cell 2009;35(6):881-8
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE, Dahlberg JE, Lund E. Reverse 5’ caps in RNAs made in vitro by phage RNA polymerases. RNA 1995;1(9):957-67
   PubMed Web of Science ®Google Scholar
• Chang H, Lim J, Ha M, Kim VN. Genome-wide Determination of Poly(A) Tail Length and 3’ End Modifications. Mol Cell 2014;53(6):1044-52
   PubMed Web of Science ®Google Scholar
• Brawerman G. The Role of the poly(A) sequence in mammalian messenger RNA. CRC Crit Rev Biochem 1981;10(1):1-38
   PubMed Web of Science ®Google Scholar
• Elango N, Elango S, Shivshankar P, Katz MS. Optimized transfection of mRNA transcribed from a d(A/T)100 tail-containing vector. Biochem Biophys Res Comm 2005;330(3):958-66
   PubMed Web of Science ®Google Scholar
• Peng J, Murray EL, Schoenberg DR. In vivo and in vitro analysis of poly(A) length effects on mRNA translation. Methods Mol Biol 2008;419:215-30
   PubMedGoogle Scholar
• Gallie DR. A tale of two termini: a functional interaction between the termini of an mRNA is a prerequisite for efficient translation initiation. Gene 1998;216(1):1-11
   PubMed Web of Science ®Google Scholar
• Michel YM, Poncet D, Piron M, et al. Cap-Poly(A) synergy in mammalian cell-free extracts. Investigation of the requirements for poly(A)-mediated stimulation of translation initiation. J Biol Chem 2000;275(41):32268-76
   PubMed Web of Science ®Google Scholar
• Newbury SF. Control of mRNA stability in eukaryotes. Biochem Soc Trans 2006;34(Pt 1):30-4
   PubMed Web of Science ®Google Scholar
• Coller J, Parker R. Eukaryotic mRNA decapping. Ann Rev Biochem 2004;73:861-90
   PubMed Web of Science ®Google Scholar
• Parker R, Sheth U. P bodies and the control of mRNA translation and degradation. Mol Cell 2007;25(5):635-46
   PubMed Web of Science ®Google Scholar
• Franks TM, Lykke-Andersen J. The control of mRNA decapping and P-body formation. Mol Cell 2008;32(5):605-15
   PubMed Web of Science ®Google Scholar
• Garneau NL, Wilusz J, Wilusz CJ. The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 2007;8(2):113-26
   PubMed Web of Science ®Google Scholar
• Schwartz D, Decker CJ, Parker R. The enhancer of decapping proteins, Edc1p and Edc2p, bind RNA and stimulate the activity of the decapping enzyme. RNA 2003;9(2):239-51
   PubMed Web of Science ®Google Scholar
• Caput D, Beutler B, Hartog K, et al. Identification of a common nucleotide sequence in the 3’-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 1986;83(6):1670-4
   PubMed Web of Science ®Google Scholar
• Klausner RD, Rouault TA, Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993;72(1):19-28
   PubMed Web of Science ®Google Scholar
• Holtkamp S, Kreiter S, Seimi A, et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 2006;108:4009-17
   PubMed Web of Science ®Google Scholar
• Sharp PM, Li WH. The codon Adaptation Index–a measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res 1987;15(3):1281-95
   PubMed Web of Science ®Google Scholar
• Qian W, Yang JR, Pearson NM, et al. Balanced codon usage optimizes eukaryotic translational efficiency. PLoS Genet 2012;8:e1002603
   Web of Science ®Google Scholar
• Kariko K, Ni H, Capodici J, et al. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004;279:12542-50
   PubMed Web of Science ®Google Scholar
• Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005;23:165-75
   PubMed Web of Science ®Google Scholar
• Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005;5:296-306
   PubMed Web of Science ®Google Scholar
• Grunebach F, Muller MR, Brossart P. RNA transfection of dendritic cells. Methods Mol Med 2005;109:47-54
   PubMedGoogle Scholar
• Strobel I, Berchtold S, Gotze A, et al. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes. Gene Ther 2000;7:2028-35
   PubMed Web of Science ®Google Scholar
• Tavernier G, Andries O, Demeester J, et al. mRNA as gene therapeutic: how to control protein expression. J Control Release 2011;150:238-47
   PubMed Web of Science ®Google Scholar
• Agapov EV, Frolov I, Lindenbach BD, et al. Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc Natl Acad Sci USA 1998;95:12989-94
   PubMed Web of Science ®Google Scholar
• Bitzer M, Armeanu S, Lauer UM, Neubert WJ. Sendai virus vectors as an emerging negative-strand RNA viral vector system. J Gene Med 2003;5:543-53
   PubMed Web of Science ®Google Scholar
• Li S, Ma Z. Nonviral gene therapy. Curr Gene Therapy 2001;1:201-26
   PubMedGoogle Scholar
• Ponsaerts P, van der Sar S, Van Tendeloo VF, et al. Highly efficient mRNA-based gene transfer in feeder-free cultured H9 human embryonic stem cells. Cloning Stem Cells 2004;6:211-16
   PubMedGoogle Scholar
• Ponsaerts P, Van Tendeloo VF, Berneman ZN. Cancer immunotherapy using RNA-loaded dendritic cells. Clin Exp Immunol 2003;134:378-84
   PubMed Web of Science ®Google Scholar
• Sohn RL, Murray MT, Schwarz K, et al. In-vivo particle mediated delivery of mRNA to mammalian tissues: ballistic and biologic effects. Wound Repair Regen 2001;9:287-96
   PubMed Web of Science ®Google Scholar
• Bettinger T, Carlisle RC, Read ML, et al. Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. Nucleic Acids Res 2001;29:3882-91
   PubMed Web of Science ®Google Scholar
• Koch G. Interaction of poliovirus-specific RNAs with HeLa cells and E. coli. Curr Top Microbiol Immunol 1973;62:89-138
   PubMedGoogle Scholar
• Fisher KJ, Wilson JM. The transmembrane domain of diphtheria toxin improves molecular conjugate gene transfer. Biochem J 1997;321(Pt 1):49-58
   PubMed Web of Science ®Google Scholar
• Huth S, Hoffmann F, von Gersdorff K, et al. Interaction of polyamine gene vectors with RNA leads to the dissociation of plasmid DNA-carrier complexes. J Gene Med 2006;8:1416-24
   PubMed Web of Science ®Google Scholar
• Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther 2002;9:1647-52
   PubMed Web of Science ®Google Scholar
• Tros de Ilarduya C, Arangoa MA, Duzgunes N. Transferrin-lipoplexes with protamine-condensed DNA for serum-resistant gene delivery. Methods Enzymol 2003;373:342-56
   PubMed Web of Science ®Google Scholar
• Noble GT, Stefanick JF, Ashley JD, et al. Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotech 2014;32:32-45
   PubMed Web of Science ®Google Scholar
• Diebold SS, Kaisho T, Hemmi H, et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004;303:1529-31
   PubMed Web of Science ®Google Scholar
• Cantara WA, Crain PF, Rozenski J, et al. The RNA Modification Database, RNAMDB: 2011 update. Nucleic Acids Res 2011;39:D195-201
   PubMed Web of Science ®Google Scholar
• Kariko K, Muramatsu H, Ludwig J, Weissman D. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res 2011;39:e142
   PubMed Web of Science ®Google Scholar
• Kormann MS, Hasenpusch G, Aneja MK, et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nature Biotechnol 2011;29:154-7
   PubMed Web of Science ®Google Scholar
• Nallagatla SR, Toroney R, Bevilacqua PC. A brilliant disguise for self RNA: 5’-end and internal modifications of primary transcripts suppress elements of innate immunity. RNA Biol 2008;5:140-4
   PubMed Web of Science ®Google Scholar
• Wang Y, Su HH, Yang Y, et al. Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy. Mol Ther 2013;21:358-67
   PubMed Web of Science ®Google Scholar
• Conry RM, LoBuglio AF, Wright M, et al. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 1995;55:1397-400
   PubMed Web of Science ®Google Scholar
• Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996;184:465-72
   PubMed Web of Science ®Google Scholar
• Saeboe-Larssen S, Fossberg E, Gaudernack G. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Methods 2002;259:191-203
   PubMed Web of Science ®Google Scholar
• Zhang HM, Zhang LW, Ren J, et al. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells. Cell Immunol 2006;239:144-50
   PubMed Web of Science ®Google Scholar
• Amano T, Kajiwara K, Yoshikawa K, et al. Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model. J Neurosurg 2007;106:638-45
   PubMed Web of Science ®Google Scholar
• Hoerr I, Obst R, Rammensee HG, Jung G. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol 2000;30:1-7
   PubMed Web of Science ®Google Scholar
• Diken M, Kreiter S, Seimi A, et al. Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation. Gene ther 2011;18:702-8
   PubMed Web of Science ®Google Scholar
• Van Lint S, Goyvaerts C, Maenhout S, et al. Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy. Cancer Res 2012;72:1661-71
   PubMed Web of Science ®Google Scholar
• Phua KK, Staats HF, Leong KW, Nair SK. Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity. Sci Rep 2014;4:5128
   PubMed Web of Science ®Google Scholar
• Phua KK, Leong KW, Nair SK. Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format. J Control Release 2013;166:227-33
   PubMed Web of Science ®Google Scholar
• Ligon TS, Leonhardt C, Rädler JO. Multi-level kinetic model of mRNA delivery via transfection of lipoplexes. PLoS One 2014;9:e107148
   PubMed Web of Science ®Google Scholar
• Leonhardt C, Schwake G, Stögbauer TR, et al. Single-cell mRNA transfection studies: delivery, kinetics and statistics by numbers. Nanomedicine 2014;10:679-88
   PubMed Web of Science ®Google Scholar